List of bibliographic references
Number of relevant bibliographic references: 10.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 6 | Humans |
| 4 | Risk Factors |
| 3 | Female |
| 3 | Hyperlipoproteinemia Type II (genetics) |
| 3 | Middle Aged |
| 2 | Anticholesteremic Agents (therapeutic use) |
| 2 | Cardiovascular Diseases (prevention & control) |
| 2 | Genetic Testing |
| 2 | Heterozygote |
| 2 | Hydroxymethylglutaryl CoA Reductases (genetics) |
| 2 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (adverse effects) |
| 2 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use) |
| 2 | Hyperlipoproteinemia Type II (diagnosis) |
| 2 | Hyperlipoproteinemia Type II (therapy) |
| 2 | Male |
| 1 | Access to Information |
| 1 | Adolescent |
| 1 | Adult |
| 1 | Aged |
| 1 | Anticholesteremic Agents (adverse effects) |
| 1 | Apolipoproteins B (blood) |
| 1 | Atherosclerosis |
| 1 | Atherosclerosis (diagnosis) |
| 1 | Atherosclerosis (drug therapy) |
| 1 | Body Mass Index |
| 1 | Body Weight (genetics) |
| 1 | Cardiology |
| 1 | Cardiovascular Diseases (blood) |
| 1 | Cardiovascular Diseases (genetics) |
| 1 | Cardiovascular disease |
| 1 | Carotid Intima-Media Thickness |
| 1 | Child |
| 1 | Cholesterol |
| 1 | Cholesterol (blood) |
| 1 | Cholesterol Ester Transfer Proteins (antagonists & inhibitors) |
| 1 | Cholesterol Ester Transfer Proteins (genetics) |
| 1 | Cholesterol, HDL (blood) |
| 1 | Cholesterol, HDL (metabolism) |
| 1 | Cholesterol, LDL (blood) |
| 1 | Cholesterol, LDL (metabolism) |
| 1 | Circulatory system |
| 1 | Clinical Laboratory Techniques (methods) |
| 1 | Clinical management |
| 1 | Cooperative Behavior |
| 1 | Cost of Illness |
| 1 | Counseling |
| 1 | Data Mining |
| 1 | Delivery of Health Care, Integrated (organization & administration) |
| 1 | Diabetes Mellitus, Type 2 (genetics) |
| 1 | Diet |
| 1 | Dietary Supplements |
| 1 | Dyslipemia |
| 1 | Early Diagnosis |
| 1 | Economics, Medical |
| 1 | Europe |
| 1 | Evidence-Based Medicine |
| 1 | Genetic Variation |
| 1 | Global Health |
| 1 | Guidance |
| 1 | High risk |
| 1 | Homozygote |
| 1 | Human |
| 1 | Hypercholesterolemia (blood) |
| 1 | Hypercholesterolemia (drug therapy) |
| 1 | Hypercholesterolemia (genetics) |
| 1 | Hyperlipoproteinemia Type II (drug therapy) |
| 1 | Hyperlipoproteinemia Type II (epidemiology) |
| 1 | Hyperlipoproteinemia Type II (mortality) |
| 1 | Hyperlipoproteinemia Type II (prevention & control) |
| 1 | Information Storage and Retrieval |
| 1 | International Cooperation |
| 1 | Life Expectancy |
| 1 | Lipids |
| 1 | Lipoprotein HDL |
| 1 | Medication Adherence |
| 1 | Mendelian Randomization Analysis |
| 1 | Muscle, Skeletal (drug effects) |
| 1 | Muscular Diseases (chemically induced) |
| 1 | Mutation |
| 1 | Organizational Objectives |
| 1 | Patient |
| 1 | Polymorphism, Single Nucleotide (genetics) |
| 1 | Pregnancy |
| 1 | Pregnancy Complications (etiology) |
| 1 | Professional Practice Gaps |
| 1 | Randomized Controlled Trials as Topic |
| 1 | Receptors, LDL (genetics) |
| 1 | Recommendation |
| 1 | Registries |
| 1 | Research Design |
| 1 | Societies, Medical |
| 1 | Treatment Outcome |
| 1 | Triglyceride |
| 1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Kausik K. Ray"
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i \
-Sk "Kausik K. Ray" \
| HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= UK
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Kausik K. Ray
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
